CCM
VPHM

Credo Capital Management’s VIROPHARMA INC VPHM Stock Holding History

Credo Capital Management’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$14K Sell
274
-427
-61% -$19.1K 0.06% 156
2013
Q3 		$28K Buy
701
+81
+13% +$2.65K 0.05% 100
2013
Q2 		$18K Buy
+620
New +$16.4K 0.01% 114

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credo Capital Management's VPHM Position: Q4 2013 in Review

Credo Capital Management reduced its VIROPHARMA INC (VPHM) stake by 61% in Q4 2013, selling an estimated $19.1K and leaving 274 shares worth $14K. The position accounts for 0.06% of the portfolio, ranked #156.

Credo Capital Management first reported a position in VPHM in Q2 2013 and has held it in 3 quarters since. The position peaked at $28K in Q3 2013. 172 funds tracked by Wall St. Rank hold VPHM as of Q4 2013.

  • Credo Capital Management held 274 shares of VIROPHARMA INC worth $14K as of Q4 2013.
  • Credo Capital Management sold 427 VIROPHARMA INC shares in Q4 2013, an estimated $19.1K.
  • VIROPHARMA INC made up 0.06% of Credo Capital Management's portfolio in Q4 2013, its #156 holding.
  • Credo Capital Management first reported a position in VIROPHARMA INC in Q2 2013 and has held it in 3 quarters since.
  • Credo Capital Management's VIROPHARMA INC position peaked at $28K in Q3 2013.
  • 172 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q4 2013.

Based on Credo Capital Management's 13F filing for Q4 2013, filed 24 Jan 2014.